Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001849 |
---|---|
Receipt number | R000002118 |
Scientific Title | phase II study of Erlotinib for non-small cell lung cancer patients with EGFR mutation |
Date of disclosure of the study information | 2009/04/04 |
Last modified on | 2012/04/23 00:46:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/04 15:49:35 | ||
2 | Update | 2009/10/28 21:44:46 | Recruitment status |
|
3 | Update | 2010/10/12 09:05:01 | Last follow-up date |
|
4 | Update | 2011/05/09 11:08:06 | Name of person sending information Organization Division name Address |
|
5 | Update | 2011/05/09 11:08:48 | Last follow-up date |
|
6 | Update | 2011/11/05 21:22:27 | Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2011/11/05 21:24:03 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2012/04/23 00:43:55 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2012/04/23 00:44:22 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2012/04/23 00:46:16 | Recruitment status |